Vitrolife AB (publ) (FRA:VTFN)

Germany flag Germany · Delayed Price · Currency is EUR
8.26
-0.04 (-0.48%)
At close: Feb 20, 2026
Market Cap1.15B -55.9%
Revenue (ttm)317.87M -4.7%
Net Income-463.12M
EPS-3.42
Shares Outn/a
PE Ration/a
Forward PE19.91
Dividend0.10 (1.21%)
Ex-Dividend DateApr 30, 2025
Volumen/a
Average Volume25
Open8.31
Previous Close8.30
Day's Range8.26 - 8.31
52-Week Range7.88 - 19.30
Betan/a
RSI27.14
Earnings DateFeb 3, 2026

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Employees 1,151
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol VTFN
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements